GoogleNews-Aggregator

... Huntington's disease, bring immense hope for the future of medicine. ... The potential of gene writing to address genetic disorders. Expanding ...Read more

... disease.” Expanded DNA repeats are responsible for more than 60 inherited diseases, such as Huntington's and myotonic dystrophy, the authors noted.Read more

Analyst Commentary. Recent research opinions on uniQure focus heavily on the FDA's decision around AMT-130 in Huntington's disease and what that means ...Read more

Note: Huntington's Disease News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or ...Read more

Well known examples include Huntington's disease, myotonic dystrophy, and some forms of ALS. While most people carry DNA repeats that slowly ...Read more

SRP-1005 is an investigational small interfering RNA (siRNA) therapeutic for the treatment of Huntington's Disease. Symptoms typically appear between ...Read more

These include devastating conditions like Huntington's disease, myotonic dystrophy, and certain forms of ALS. Most people carry DNA repeats that ...Read more

DNA mismatch repair has been shown as a key driver of Huntington's disease and other triplet repeat diseases, with evidence identifying MSH3/MutSβ as ...Read more

... Huntington's disease, to New Zealand's Medsafe regulatory authority. The biotech company, currently valued at $2.34 billion, appears undervalued ...Read more

Sarepta Therapeutics (SRPT, Financial) has submitted a clinical trial application for its investigational drug SRP-1005 targeting Huntington's Disease ...Read more

SRP-1005 is an investigational small interfering RNA therapeutic for the treatment of Huntington's Disease. Claim 70% Off TipRanks Premium. Unlock ...Read more

SRP-1005 is an investigational small interfering RNA (siRNA) therapeutic for the treatment of Huntington's Disease.Read more

Sarepta submits clinical trial application for Huntington's disease drug. January 7, 2026 8:31 AM. Sarepta Therapeutics Inc. (NASDAQ: SRPT) submitted ...Read more

Huntington's Disease (HD) is a rare and ultimately fatal inherited neurodegenerative disorder which is passed down from generation to generation ...Read more

Huntington's Disease Clinical Trials: Innovation, Challenges, And The Road Ahead · Lupus Community Tackles Treatment & Clinical Trial Barriers ...Read more